Morgan Stanley Cuts Accenture Target 25% to $240
Morgan Stanley delivered a significant revision to its outlook on Accenture (NYSE: ACN) on March 16, slashing its price target by 25% from $320 down to $240 per share. The move signals growing caution over the professional services giant's near-term performance. Despite the substantial cut, the investment bank maintained its "Overweight" rating on the stock, indicating a belief in the company's long-term value but acknowledging significant immediate headwinds.
Analyst Consensus Dims Ahead of Q2 Earnings
The downgrade from Morgan Stanley is not an isolated event but the latest in a series of cautious revisions from Wall Street. On March 10, Truist Securities reduced its price target to $260 from $317, citing checks that suggest the demand environment for enterprise AI remains "stagnant." Earlier, on March 5, TD Cowen also trimmed its target to $282 from $300. This pattern of downward revisions from multiple firms ahead of Accenture's second-quarter results points to a broader market re-evaluation of the IT consulting sector's growth trajectory.
Stagnant Spending Pressures Future Growth Estimates
The core tension for Accenture is a conflict between the long-term promise of artificial intelligence and the current reality of client spending. Analysts at Truist warned that while frontier AI models continue to improve, slower spending from ecosystem partners and potential "AI-driven cannibalization" of existing services could pressure consensus estimates for fiscal year 2027. While most analysts, including TD Cowen, still hold "Buy" or equivalent ratings, they acknowledge a lack of clear catalysts that could materially shift negative sentiment in the short term.
Edgen Stock·Mar 16 2026, 16:09
